首页> 外文期刊>Hong Kong Journal of Paediatrics >Picibanil Therapy for Cervicofacial Lymphatic Malformation
【24h】

Picibanil Therapy for Cervicofacial Lymphatic Malformation

机译:Picibanil治疗颈面部淋巴畸形

获取原文
       

摘要

We present the case of a 4-year-old boy who was born with a large cervicofacial lymphatic malformation. It was partially resected in the first year of life and treated with Picibanil/OK-432 injections at the age of three because of recurrence. Eight months later the boy developed a fulminant streptococcal toxic shock syndrome with cardiac arrest. After resuscitation, high dose intravenous antibiotic therapy and artificial ventilation for 2 weeks, he remained with an extensive hypoxic brain damage. As Picibanil/OK-432 is a preparation of lyophilized, low virulence group A Streptococcus pyogenes cells of human origin, the question of a causative relationship for the tragic outcome arises. We therefore report the clinical course and discuss the action and possible side effects of Picibanil/OK-432.
机译:我们介绍了一个4岁男孩的病例,该男孩出生时患有大的颈面部淋巴畸形。它在生命的第一年被部分切除,由于复发,在三岁时接受Picibanil / OK-432注射治疗。八个月后,男孩发展为暴发性链球菌中毒性休克综合征,并伴有心脏骤停。复苏,大剂量静脉内抗生素治疗和人工通气2周后,他仍然患有广泛的缺氧性脑损伤。由于Picibanil / OK-432是人源性冻干,低毒力的化脓性链球菌A群细胞的制剂,因此出现了有关悲剧性结局的问题。因此,我们报告了临床过程并讨论了Picibanil / OK-432的作用和可能的副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号